Patenting biotech at the EPO
The patenting of biotechnology raises both ethical and practical concerns. Dirk Bühler and Martin Huenges of Maiwald analyse recent cases to consider how the EPO is handling the issues
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: